189 related articles for article (PubMed ID: 28684545)
21. Adipose-Derived Mesenchymal Stem Cells Ameliorating
Li LL; Zhu YG; Jia XM; Liu D; Qu JM
Front Cell Infect Microbiol; 2020; 10():581535. PubMed ID: 33489931
[TBL] [Abstract][Full Text] [Related]
22. Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis.
Kawamura-Sato K; Iinuma Y; Hasegawa T; Horii T; Yamashino T; Ohta M
Antimicrob Agents Chemother; 2000 Oct; 44(10):2869-72. PubMed ID: 10991876
[TBL] [Abstract][Full Text] [Related]
23. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa.
Saini H; Vadekeetil A; Chhibber S; Harjai K
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194
[No Abstract] [Full Text] [Related]
24. Membrane vesicles from Pseudomonas aeruginosa activate the noncanonical inflammasome through caspase-5 in human monocytes.
Bitto NJ; Baker PJ; Dowling JK; Wray-McCann G; De Paoli A; Tran LS; Leung PL; Stacey KJ; Mansell A; Masters SL; Ferrero RL
Immunol Cell Biol; 2018 Nov; 96(10):1120-1130. PubMed ID: 30003588
[TBL] [Abstract][Full Text] [Related]
25. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection.
Tsai WC; Rodriguez ML; Young KS; Deng JC; Thannickal VJ; Tateda K; Hershenson MB; Standiford TJ
Am J Respir Crit Care Med; 2004 Dec; 170(12):1331-9. PubMed ID: 15361366
[TBL] [Abstract][Full Text] [Related]
26. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.
Burr LD; Rogers GB; Chen AC; Hamilton BR; Pool GF; Taylor SL; Venter D; Bowler SD; Biga S; McGuckin MA
Ann Am Thorac Soc; 2016 Oct; 13(10):1697-1703. PubMed ID: 27464029
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.
Molinari G; Guzmán CA; Pesce A; Schito GC
J Antimicrob Chemother; 1993 May; 31(5):681-8. PubMed ID: 8392997
[TBL] [Abstract][Full Text] [Related]
28. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
29. [Effect of macrolides on biofilm of mucoid Pseudomonas aeruginosa].
Chai D; Wang R; Pei F
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):934-6. PubMed ID: 11702671
[TBL] [Abstract][Full Text] [Related]
30. Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas.
Feola DJ; Garvy BA; Cory TJ; Birket SE; Hoy H; Hayes D; Murphy BS
Antimicrob Agents Chemother; 2010 Jun; 54(6):2437-47. PubMed ID: 20231397
[TBL] [Abstract][Full Text] [Related]
31. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
32. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
Li W; Qin Z; Gao J; Jiang Z; Chai Y; Guan L; Chen Y
Chron Respir Dis; 2019; 16():1479972318790269. PubMed ID: 30101613
[TBL] [Abstract][Full Text] [Related]
33. Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases.
Hodge S; Tran HB; Hamon R; Roscioli E; Hodge G; Jersmann H; Ween M; Reynolds PN; Yeung A; Treiberg J; Wilbert S
Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L678-L687. PubMed ID: 28258107
[TBL] [Abstract][Full Text] [Related]
34. Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia.
Kikuchi Y; Tateda K; Fuse ET; Matsumoto T; Gotoh N; Fukushima J; Takizawa H; Nagase T; Standiford TJ; Yamaguchi K
Pulm Pharmacol Ther; 2009 Aug; 22(4):333-9. PubMed ID: 19162211
[TBL] [Abstract][Full Text] [Related]
35. AIM2 inflammasome is dispensable for the host defense against Pseudomonas aeruginosa infection.
Pang Z; Sun G; Junkins RD; Lin TJ
Cell Mol Biol (Noisy-le-grand); 2015 Jun; 61(3):63-70. PubMed ID: 26107502
[TBL] [Abstract][Full Text] [Related]
36. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J
Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017
[TBL] [Abstract][Full Text] [Related]
37. Combination of Azithromycin and Gentamicin for Efficient Treatment of Pseudomonas aeruginosa Infections.
Ren H; Liu Y; Zhou J; Long Y; Liu C; Xia B; Shi J; Fan Z; Liang Y; Chen S; Xu J; Wang P; Zhang Y; Zhu G; Liu H; Jin Y; Bai F; Cheng Z; Jin S; Wu W
J Infect Dis; 2019 Oct; 220(10):1667-1678. PubMed ID: 31419286
[TBL] [Abstract][Full Text] [Related]
38. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
39. Low expression of T-cell co-stimulatory molecules in bone marrow-derived dendritic cells in a mouse model of chronic respiratory infection with Pseudomonas aeruginosa.
Mukae H; Urabe K; Yanagihara K; Ishimoto H; Sakamoto N; Ishii H; Nakayama S; Ishimatsu Y; Abe K; Shirai R; Kohno S
Tohoku J Exp Med; 2010 Jan; 220(1):59-65. PubMed ID: 20046053
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS
Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
